Note: Ingredients listed on restricted chemical lists
EC/CAS
7681-57-4
Name of the chemical
Sodium metabisulfite
Concentration
0.1%
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
2.0%
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2013-09-10
Product name
Physostigmine Salicylate Injection, 0.1%
Product Synonyms
of Active Ingredient Physostigmine Salicylate, Eserine salicylate
Manufacturer Name
Akorn Pharmaceuticals
Icons in SDS
Company Information
company name
Akorn Pharmaceuticals
Section 2
SECTION 2: Hazards identification
Principle Routes of Exposure
For intramuscular or intravenous injection Physostigmine salicylate is toxic to the nervous system.
Health hazards
Mutagenicity: NA
Teratogenic Effects
NA Developmental toxicity: NA Eye: Very hazardous, irritant. Skin: Slightly Hazardous, irritiant. Ingestion: Extremely hazardous. Inhalation: Very hazardous. Carcinogenicity: National Toxicology Program (NTP): No International Agency for Research on Cancer (IARC): No Occupational Safety and Health Administration
